Boston Scientific is at the forefront of medical innovation, focusing on developing advanced technologies that address various health conditions. Their product offerings include a range of electrophysiology solutions, such as the DIREX™ Steerable Sheath and the OPAL HDx Mapping System, which enhance catheter access and mapping capabilities during cardiac procedures. The company also emphasizes the importance of cardiac resynchronization therapy (CRT) devices, like the DYNAGEN™ X4 and VIGILANT™ X4, which utilize EnduraLife™ Battery Technology to improve patient outcomes and reduce complications associated with battery replacements. Additionally, Boston Scientific's commitment to innovation is evident in their cardiac ablation systems, such as the MAESTRO 4000™ and the FARAPULSE™ Pulsed Field Ablation System, which aim to provide effective treatment for atrial fibrillation while minimizing damage to surrounding tissues.

In the realm of neuromodulation, Boston Scientific offers the Spectra WaveWriter™ SCS System for chronic pain management, showcasing their dedication to improving patient quality of life. Their research initiatives, including the Investigator-Sponsored Research Program, further highlight their commitment to advancing medical knowledge and understanding the efficacy of their products. By fostering collaboration with external researchers, Boston Scientific aims to enhance the clinical and economic outcomes associated with their innovative medical devices, ultimately transforming lives and improving healthcare delivery worldwide.

United States

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.

Boston Scientific

Company Details